{"id":111895,"date":"2023-08-07T11:10:29","date_gmt":"2023-08-07T11:10:29","guid":{"rendered":"https:\/\/learnexams.com\/blog\/?p=111895"},"modified":"2023-08-07T11:10:36","modified_gmt":"2023-08-07T11:10:36","slug":"citi-training-modules-1-24-biomedical-research-2022-questions-and-answers-with-complete-solution","status":"publish","type":"post","link":"https:\/\/www.learnexams.com\/blog\/2023\/08\/07\/citi-training-modules-1-24-biomedical-research-2022-questions-and-answers-with-complete-solution\/","title":{"rendered":"CITI Training, Modules 1-24 (Biomedical Research) 2022 Questions and Answers With Complete Solution"},"content":{"rendered":"\n<p>CITI Training, Modules 1-24 (Biomedical Research) 2022<br>Questions and Answers With Complete Solution<br>A 46-year-old man is currently enrolled in a Phase 2 study of a drug for severe diabetic neuropathy.<br>While the study is on-going, a new drug becomes commercially available that may have equal or<br>greater benefit to the subject. The investigator should do which of the following?<br>A. Do not tell the subject about the new drug because physicians have the right to try out new<br>treatments with their patients.<br>B. Withhold this new information to avoid confusing the subject with other treatment options or<br>alternatives.<br>C. Give the subject comprehensive information about the new drug, including its side effects.<br>Discuss the pros and cons of both the investigational drug and the commercially available drug and<br>then allow the subject to decide whether to withdraw from the research to take the new drug.<br>D. Tell the subject about the new drug but discourage him from switching treatments until the<br>study is completed. &#8211; C. Give the subject comprehensive information about the new drug, including<br>its side effects. Discuss the pros and cons of both the investigational drug and the commercially<br>available drug and then allow the subject to decide whether to withdraw from the research to take<br>the new drug.<br>A clinician may use a HUD without IRB approval:<br>A. In a clinical investigation to collect data on an HDE approved indication.<br>B. For compassionate use where no alternative device is available for a patient&#8217;s condition.<br>C. If the clinician determines that approval from an IRB cannot be obtained in time to prevent<br>serious harm or death to a patient.<br>D. For clinical use only. &#8211; C. If the clinician determines that approval from an IRB cannot be obtained<br>in time to prevent serious harm or death to a patient.<br>A Data Safety Monitoring Board report for an investigator-initiated investigational drug study<br>indicates a significantly higher than anticipated rate of an expected adverse event. This event<br>required revision of the informed consent form to disclose the higher rate. A change in the<br>eligibility criteria of the protocol to reduce the risk was implemented. Current subjects would be<br>reconsented.<br>A. This is not an unanticipated problem because the adverse event was acknowledged in the<br>consent form.<br>B. This is an unanticipated problem.<br>C. Current subjects should never be reconsented.<\/p>\n\n\n\n<p>D. This study was an investigator-initiated study. There is no need to report to the IRB or any<br>federal agency. &#8211; B. This is an unanticipated problem.<br>A federally funded research study involving children 8 to 12 years old involves collecting a single<br>voided urine sample to assess the frequency of asymptomatic proteinuria (higher amounts of<br>protein in the urine without any signs or symptoms of illness or infection). According to 45 CFR 46,<br>an IRB&#8217;s risk assessment would likely conclude that this study involves:<br>A. No risk to the child and no further IRB review is required.<br>B. No more than minimal risk to the child.<br>C. More than minimal risk with no prospect of direct benefit to the child.<br>D. More than minimal risk with prospect of direct benefit to the child. &#8211; B. No more than minimal<br>risk to the child.<br>A federally funded research study involving children 8 to 12 years old involves collecting a single<br>voided urine sample to assess the frequency of asymptomatic proteinuria (higher amounts of<br>protein in the urine without any signs or symptoms of illness or infection). Your IRB has<br>determined that assent of children age 8 and older is required for the study. A 10-year-old firmly<br>declined to participate in the study described above. Which of the following procedures best<br>describes the action to be taken by the investigator?<br>A. Consent both of the child&#8217;s parents instead.<br>B. Request the child reconsider assenting to the study.<br>C. Honor the child&#8217;s decision.<br>D. Seek permission from one of the child&#8217;s parent instead. &#8211; C. Honor the child&#8217;s decision.<br>A general requirement for the informed consent form is that it may not include any exculpatory<br>language. Exculpatory language is that which waives or appears to waive any of the subject&#8217;s legal<br>rights or releases or appears to release those conducting the research from liability for negligence.<br>Which of the following statements in a consent form is an example of exculpatory language?<br>A. In the event of any injury you may have related to this research, you will be given medical<br>treatment.<br>B. Your participation in this research is voluntary. If you choose not to participate, or change your<br>mind later, your decision will not affect your relationship with your doctor or your right to health<br>care or other services that you may be eligible for.<br>C. The investigator may stop you from participating in this research without your consent if you<br>experience side effects that make your condition worse. If you become ill during the research, you<br>may have to drop out.<\/p>\n\n\n\n<p>D. I waive any possibility of compensation for injuries that I may receive as a result of participation<br>in this research. &#8211; D. I waive any possibility of compensation for injuries that I may receive as a<br>result of participation in this research.<br>A HIPAA authorization has which of the following characteristics:<br>A. Cannot be revoked by the data subject.<br>B. Cannot be combined with any other document related to the research.<br>C. Is provided at the investigator&#8217;s discretion.<br>D. Uses &#8220;plain language&#8221; that the data subject can understand, similar to the requirement for an<br>informed consent document. &#8211; D. Uses &#8220;plain language&#8221; that the data subject can understand, similar<br>to the requirement for an informed consent document.<br>A Humanitarian Use Device (HUD) is a medical device:<br>A. Used to treat or diagnose a very common serious disease or condition where the likelihood of<br>death is high unless the device is used<br>B. Used to treat or diagnose a common disease or condition in individuals who do not qualify for<br>participation in a clinical trial.<br>C. Used to treat or diagnose a disease or condition that affects not more than 8,000 individuals in<br>the U.S. annually.<br>D. That is proven to be safe and effective and is provided at no cost for qualifying patients. &#8211; C. Used<br>to treat or diagnose a disease or condition that affects not more than 8,000 individuals in the U.S.<br>annually.<br>A research collaboration can be enhanced by:<br>A. Discussing intellectual property issues while the collaboration is forming.<br>B. Limiting the communication between researchers and industry partners.<br>C. Waiting to discuss authorship issues until after data collection.<br>D. Avoiding the issue of which journal to target since research team members might disagree. &#8211; A.<br>Discussing intellectual property issues while the collaboration is forming.<br>A research study aims to evaluate a new experimental type of fetoscopic laser surgery to correct a<br>potentially life-threatening condition for the fetus prior to delivery. This research is to meet the<br>health needs and directly benefit the fetus only. The pregnant woman is otherwise healthy. Per<br>Subpart B, the investigator must obtain consent from whom?<\/p>\n\n\n\n<p>A. The father of the fetus only.<br>B. The pregnant woman and the father of the fetus (except if he is unable to consent because of<br>unavailability, incompetence, or temporary incapacity or the pregnancy resulted from rape or<br>incest).<br>C. The pregnant woman only.<br>D. The state court where the research is taking place &#8211; B. The pregnant woman and the father of the<br>fetus (except if he is unable to consent because of unavailability, incompetence, or temporary<br>incapacity or the pregnancy resulted from rape or incest).<br>A research study wants to determine the effectiveness of two prenatal care group programs as<br>compared to individual prenatal care in reducing the risk for HIV in young women during and after<br>pregnancy. The IRB determines the research is no greater than minimal risk for the pregnant<br>women and the fetuses. Is this research permitted under Subpart B?<br>A. No &#8211; this research is not permitted because it involves fetuses.<br>B. Yes &#8211; this research is permitted.<br>C. This research is only permitted if it also presents a direct benefit to the mother and the fetus.<br>D. No &#8211; this research is not permitted with pregnant women. &#8211; Yes &#8211; this research is permitted.<br>A research study will compare a new combined behavioral and pharmacologic treatment with the<br>standard behavioral treatment alone for individuals with severe seasonal affected disorder (SAD).<br>The researcher wants to include pregnant women in the study. However, the pharmacologic<br>treatment has not been previously studied in non-pregnant women, nor have preclinical studies on<br>pregnant animals been conducted. Is this research permitted under Subpart B?<br>A. Yes- This research is permitted if because it may benefit the pregnant women.<br>B. No &#8211; this research is not permitted because it involves fetuses.<br>C. No &#8211; this research is not permitted with pregnant women.<br>D. Yes &#8211; this research is permitted. &#8211; C. No &#8211; this research is not permitted with pregnant women.<br>A researcher is conducting a written survey about people&#8217;s attitudes toward walking as an exercise<br>option at the local shopping mall that supports a walking program. The survey is anonymous<br>(without codes, names, or other information) and subjects may complete the survey and place it in<br>a box at the shopping mall exits. Which of the following is the most important issue that the<br>researcher addressed in planning the research?<br>A. Possibility of emotional distress for subjects from the questions themselves<br>B. Data analysis from a large sample size<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CITI Training, Modules 1-24 (Biomedical Research) 2022Questions and Answers With Complete SolutionA 46-year-old man is currently enrolled in a Phase 2 study of a drug for severe diabetic neuropathy.While the study is on-going, a new drug becomes commercially available that may have equal orgreater benefit to the subject. The investigator should do which of the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[],"tags":[],"class_list":["post-111895","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts\/111895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/comments?post=111895"}],"version-history":[{"count":0,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/posts\/111895\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/media?parent=111895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/categories?post=111895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.learnexams.com\/blog\/wp-json\/wp\/v2\/tags?post=111895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}